Live from the NIH registry
Studies recruiting near Fontana right now
Top 25 of 990 recruiting studies, sorted by proximity — each links to its official registry page
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
Loma Linda University Medical Center (Adults only) — Loma Linda, California (11.9 mi)
· Sponsor: Pierre Fabre Medicament
Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma
B-Cell Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma
Phase 1
Interventional 15 participants sought
City of Hope Medical Center — Duarte, California (29.7 mi)
· Sponsor: City of Hope Medical Center
Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
Age-Related Macular Degeneration, Geographic Atrophy
N/A
Interventional 125 participants sought
Loma Linda University — Loma Linda, California (11.9 mi)
· Sponsor: VisionCare, Inc.
Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
Neuromyelitis Optica Spectrum Disorder
Phase 2
Interventional 15 participants sought
Loma Linda University Children's Hospital - PIN — Loma Linda, California (11.9 mi)
· Sponsor: Amgen
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Loma Linda University Medical Center — Loma Linda, California (11.9 mi)
· Sponsor: National Cancer Institute (NCI)
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
City of Hope Comprehensive Cancer Center ( Site 0191) — Duarte, California (29.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
City of Hope National Medical Center — Duarte, California (29.7 mi)
· Sponsor: Relay Therapeutics, Inc.
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Loma Linda University Medical Center — Loma Linda, California (11.9 mi)
· Sponsor: Medtronic MiniMed, Inc.
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Multiple Myeloma
Phase 1
Interventional 127 participants sought
City of Hope National Medical Center /ID# 280273 — Duarte, California (29.7 mi)
· Sponsor: AbbVie
Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma
Folliculotropic Mycosis Fungoides, Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma
Phase 1, Phase 2
Interventional 78 participants sought
City of Hope Medical Center — Duarte, California (29.7 mi)
· Sponsor: City of Hope Medical Center
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
Carcinoma, Non-Small-Cell Lung
Phase 1, Phase 2
Interventional 450 participants sought
City of Hope ( Site 0014) — Duarte, California (29.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 1
Interventional 15 participants sought
City of Hope Medical Center — Duarte, California (29.7 mi)
· Sponsor: City of Hope Medical Center
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
Heart Failure
Phase 2
Interventional 200 participants sought
Valley Clinical Trials — Covina, California (24.6 mi)
· Sponsor: Novo Nordisk A/S
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Duarte, California (29.7 mi)
· Sponsor: AstraZeneca
Horizon Two: HR NDMM (MMRC-100)
High Risk Newly Diagnosed Multiple Myeloma
Phase 2
Interventional 300 participants sought
City of Hope — Duarte, California (29.7 mi)
· Sponsor: Multiple Myeloma Research Consortium
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Acute Myeloid Leukemias
Phase 3
Interventional 468 participants sought
Clinical Trial Site — Duarte, California (29.7 mi)
· Sponsor: Syndax Pharmaceuticals
Duvelisib Maintenance for the Treatment of Peripheral T-Cell Lymphomas
Follicular Helper T-Cell Lymphoma, Peripheral T-Cell Lymphoma, Not Otherwise Specified
Phase 2
Interventional 25 participants sought
City of Hope Medical Center — Duarte, California (29.7 mi)
· Sponsor: City of Hope Medical Center
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Colorectal Cancer, Colorectal Cancer (CRC)
Phase 1
Interventional 80 participants sought
City of Hope Duarte — Duarte, California (29.7 mi)
· Sponsor: Cartography Biosciences
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
Thyroid Gland Nodule
N/A
Observational 22 participants sought
City of Hope Medical Center — Duarte, California (29.7 mi)
· Sponsor: City of Hope Medical Center
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Kaiser Permanente-Fontana — Fontana, California (1.5 mi)
· Sponsor: SWOG Cancer Research Network
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
Phase 1
Interventional 248 participants sought
City of Hope — Duarte, California (29.7 mi)
· Sponsor: Nurix Therapeutics, Inc.
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer, c-MET
Phase 3
Interventional 768 participants sought
City of Hope /ID# 243157 — Duarte, California (29.7 mi)
· Sponsor: AbbVie
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Systemic Sclerosis Associated Interstitial Lung Disease, Scleroderma, Systemic
Phase 2, Phase 3
Interventional 300 participants sought
GSK Investigational Site — Upland, California (10.8 mi)
· Sponsor: GlaxoSmithKline
First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)
Advanced Metastatic Castration-resistant Prostate Cancer, Prostate Specific Membrane Antigen (PSMA) Expression
Phase 1
Interventional 198 participants sought
City of Hope - Duarte Cancer Center — Duarte, California (29.7 mi)
· Sponsor: Bayer
Integrating CHWs Into Prenatal Care for Maternal Smoking Cessation
Tobacco Use, Tobacco Use Cessation
N/A
Interventional 105 participants sought
Loma Linda University Medical Center — Loma Linda, California (11.9 mi)
· Sponsor: Loma Linda University